In last trading session, Chemomab Therapeutics Ltd ADR (NASDAQ:CMMB) saw 0.14 million shares changing hands with its beta currently measuring 0.61. Company’s recent per share price level of $1.78 trading at $0.19 or 11.95% at ring of the bell on the day assigns it a market valuation of $33.57M. That closing price of CMMB’s stock is at a discount of -43.26% from its 52-week high price of $2.55 and is indicating a premium of 76.4% from its 52-week low price of $0.42. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.13 million shares which gives us an average trading volume of 192.22K if we extend that period to 3-months.
For Chemomab Therapeutics Ltd ADR (CMMB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Chemomab Therapeutics Ltd ADR (NASDAQ:CMMB) trade information
Upright in the green during last session for gaining 11.95%, in the last five days CMMB remained trading in the green while hitting it’s week-highest on Wednesday, 11/27/24 when the stock touched $1.78 price level, adding 0.98% to its value on the day. Chemomab Therapeutics Ltd ADR’s shares saw a change of 249.02% in year-to-date performance and have moved 8.54% in past 5-day. Chemomab Therapeutics Ltd ADR (NASDAQ:CMMB) showed a performance of 23.61% in past 30-days. Number of shares sold short was 0.16 million shares which calculate 1.15 days to cover the short interests.
Chemomab Therapeutics Ltd ADR (CMMB) estimates and forecasts
Statistics highlight that Chemomab Therapeutics Ltd ADR is scoring comparatively higher than the scores of other players of the relevant industry. The company added 67.92% of value to its shares in past 6 months, showing an annual growth rate of 51.46% while that of industry is 17.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 37.62% during past 5 years.
